Where Hospitals Get it Wrong on Pain and Opioids
If you turn on the nightly news or open a daily paper, you’re likely to hear about the nation’s ongoing opioid abuse crisis.
FDA to Tweak Naming System for Biological Medicines
One key to tracing how innovative biological medicines impact patients hinges on a deceptively simple issue: how the drugs are named.
U.S. is Missing the Mark on Hepatitis C Elimination
When it comes to curing hepatitis C, the United States is at the bottom of the barrel.
Moving Beyond Stigma for People Living with TD
Patient advocates want the lip smacking, grimacing and uncontrollable twitching caused by the movement disorder tardive dyskinesia to do more than attract stares. They want it to elicit empathy and understanding.
For Skin Patients, the Waiting Never Ends
If you live in Philadelphia, you may wait 78 days. In Cedar Rapids, 91 days.
CMS Limits “Co-Pay Surprise” for Obamacare Patients
Patients with an Affordable Care Act health plan will soon have one less hurdle between them and the medicine they need to manage chronic or rare diseases.
What Heart Attack & Stroke Mean to EU Workplaces
Heart attack and stroke don’t just affect patients across Europe, new research reveals.
The Medicare Solution
Still more than a year ahead of 2020 presidential elections, the battle over how to “fix” health care in America is reaching fever pitch.
Insurance Barriers Are Parkinson’s Doctors’ Other Battle
These days, I find myself using some of the same words to describe Parkinson’s as I do to describe the experience of physicians like me who treat patients with the disease. It’s a sad reflection on current health insurer practices.
Biologics Summit Explores “The Value Proposition”
Languishing in a hospital bed after surgery for life-threatening Crohn’s disease, San Diego Chargers’ Rolf Benirschke, dangerously underweight and saddled with ostomy bags at only 24 years old, couldn’t see the value of going on.
